Loading publications…
The last 5 uploaded publications
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
Liwei Zhao, Peng Liu, Allan Sauvat, Killian Carnet Le Provost, Jiani Liu, Andrea Checcoli, Jonathan Pol, Oliver Kepp, Guido Guido Kroemer, Lucillia Bezu (2025). Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade. , 13(6), DOI: https://doi.org/10.1136/jitc-2024-010714.
Article73 days agoTrial watch: local anesthetics in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Guido Kroemer, Lucillia Bezu (2024). Trial watch: local anesthetics in cancer therapy. , 13(1), DOI: https://doi.org/10.1080/2162402x.2024.2308940.
Article73 days agoImmunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
Lucillia Bezu, Oliver Kepp, Guido Guido Kroemer (2023). Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors. , 12(1), DOI: https://doi.org/10.1080/2162402x.2023.2272352.
Editorial material73 days agoTrial watch: dexmedetomidine in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Guido Kroemer, Lucillia Bezu (2024). Trial watch: dexmedetomidine in cancer therapy. , 13(1), DOI: https://doi.org/10.1080/2162402x.2024.2327143.
Article73 days agoTrial watch: beta-blockers in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Guido Kroemer, Lucillia Bezu (2023). Trial watch: beta-blockers in cancer therapy. , 12(1), DOI: https://doi.org/10.1080/2162402x.2023.2284486.
Article73 days ago